Table 2.
Baseline characteristics for the different treatment groups.
| Placebo group (n = 49) | Active group (n = 57) | Total (n = 106) | |
|---|---|---|---|
| Age (mean, SD) | 86.0 (6.6) | 85.2 (7.8) | 85.5 (7.3) |
| Female (%) | 80 | 74 | 76 |
| MMSE (mean, SD) | 6.9 (5.8) | 8.2 (6.1) | 7.6 (6.0) |
| MOBID-2 (mean, SD) | 3.2 (2.3) | 2.6 (1.9) | 2.8 (2.1) |
| CSDD (mean, SD) | 11.4 (4.1) | 11.0 (3.4) | 11.2 (3.7) |
The table reports baseline characteristics for several central variables in the placebo group and the active group: age, sex, mini mental status examination score (MMSE), Mobilization-Observation-Behavior-Intensity-Dementia-2 Pain Scale score (MOBID-2), Cornell Scale for Depression in Dementia score (CSDD). No statistical significant differences were found between the groups.